Simple Summary Breast cancer is the most common cancer affecting women under 40 years
of age worldwide, with an increasing number of cases diagnosed each year. Despite this …

In the era of personalized medicine, there has been significant progress regarding the
molecular analysis of breast cancer subtypes. The major classification schemes are based …

Background In patients with early-stage triple-negative breast cancer, the phase 3
KEYNOTE-522 trial showed significant improvements in pathological complete response …

Using quantitative radiomics, we demonstrate that computer-extracted magnetic resonance
(MR) image-based tumor phenotypes can be predictive of the molecular classification of …

Purpose The risk of local and regional relapse associated with each breast cancer
molecular subtype was determined in a large cohort of patients with breast cancer. Subtype …

MRI is used widely both for screening women who are at increased risk of breast cancer and
for treatment selection. Prospective studies confirm that MRI screening of women with known …

Triple-negative breast cancer (TNBC) is defined by a lack of expression of both estrogen
and progesterone receptor as well as human epidermal growth factor receptor 2. It is …

Molecular subty** confirms that breast cancer comprises at least four genetically distinct
entities based on the expression of specific genes including estrogen receptor (ER) …

The past half century—the lifetime of the American Society of Clinical Oncology—represents
a historical watershed in the management of breast cancer, a period in which old dogmas …

Previous studies have demonstrated that androgen receptor is expressed in many breast
cancers, but its expression in relation to the various breast cancer subtypes as defined by …